Effects of etanercept in patients with the metabolic syndrome (II).
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2010
At a glance
- Drugs Etanercept (Primary)
- Indications Glucose intolerance; Metabolic syndrome; Obesity
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 06 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 Apr 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History